Intas Pharmaceuticals Ltd.
USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Intas ranks #18,766 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.
- #18,766
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (40.9/100)
- 8.9
- avg claims per patent
- +17%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18766 · Foreign Corporation #18,766 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-UP · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #18,766/49,997
- PHOTO-FINISH Innovative Surgical…
- CPC-NARROW A61K · 7 areas
- INNOV-PAR 40.9/100
- CLAIMS-PAR 8.9 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-UP +17% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Innovative Surgical Solutions, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Intas’s 40.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Intas
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Intas Pharmaceuticals · this assignee
Intas Pharmaceuticals · this assignee
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Intas's Innovation Score is 40.9/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Intas?
Each dot is one of Intas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Intas’s own 8.9 claims/patent is at or below the 17.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Intas's grants concentrate
Intas Pharmaceuticals Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 73.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2020. By volume, Intas sits between Innovative Surgical Solutions, LLC and Intrado Life & Safety, Inc..
Intas's three-year grant acceleration
Intas Pharmaceuticals Ltd. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Intas's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Innovative Surgic…
Innovative Surgical Solutions, LLC
15 patents
- Institute for Env…
Institute for Environmental Health, Inc.
15 patents
- Institute of Elec…
Institute of Electrical Engineering, Chinese Academy of Sciences
15 patents
- Institute of Micr…
Institute of Microbiology Chinese Academy of Sciences
15 patents
- Intelligent Fiber…
Intelligent Fiber Optic Systems Corporation
15 patents
- Interlight Optote…
Interlight Optotech Corporation
15 patents
- Interset Software
Interset Software Inc.
15 patents
- Intrado Life & Sa…
Intrado Life & Safety, Inc.
15 patents
- Intas Pharmaceuti… ◀
Intas Pharmaceuticals Ltd.
15 patents
What this shows Intas holds 15 patents at rank #18,769, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Intas
By rank, the assignees closest to #18,769 in granted patent volume.
- Innovative Surgical Solutions, LLC #18,765 · 15 patents
- Institute for Environmental Health, Inc. #18,766 · 15 patents
- Institute of Electrical Engineering, Chinese Academy of Sciences #18,767 · 15 patents
- Institute of Microbiology Chinese Academy of Sciences #18,768 · 15 patents
- Intelligent Fiber Optic Systems Corporation #18,770 · 15 patents
- Interlight Optotech Corporation #18,771 · 15 patents
- Interset Software Inc. #18,772 · 15 patents
- Intrado Life & Safety, Inc. #18,773 · 15 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Intas's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Intas's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 20.0% |
| 2018 | 3 | 20.0% |
| 2020 | 1 | 6.7% |
| 2021 | 1 | 6.7% |
| 2022 | 2 | 13.3% |
| 2023 | 2 | 13.3% |
| 2024 | 1 | 6.7% |
| 2025partial year | 2 | 13.3% |
Which technologies does Intas Pharmaceuticals Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Intas Pharmaceuticals Ltd.'s patent record in context - here's where to go next.
- Intas Pharmaceuticals Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 73.3% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #18,766 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Intas Pharmaceuticals Ltd. against Innovative Surgical Solutions, LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 40.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.